NeuroOne Medical Technologies Corporation Proceeds from Warrant Exercises
NeuroOne Medical Technologies Corporation (NMTC) reported Proceeds from Warrant Exercises of $174.37 thousand for the 9-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromWarrantExercises · last filed 2026-08-13
- NeuroOne Medical Technologies Corporation proceeds from warrant exercises for the quarter ending 2026-06-30 was $0.00.
- NeuroOne Medical Technologies Corporation proceeds from warrant exercises for the quarter ending 2026-03-31 was -$1.00.
- NeuroOne Medical Technologies Corporation proceeds from warrant exercises for the quarter ending 2025-12-31 was $174.38K.
- NeuroOne Medical Technologies Corporation proceeds from warrant exercises for the quarter ending 2024-06-30 was $0.00.
- NeuroOne Medical Technologies Corporation proceeds from warrant exercises for fiscal 2025 was $69.75K.
- NeuroOne Medical Technologies Corporation proceeds from warrant exercises for fiscal 2021 was $275.00K.
- NeuroOne Medical Technologies Corporation proceeds from warrant exercises for fiscal 2019 was $416.33K.
| Period end | Proceeds from Warrant Exercises 3 month | Proceeds from Warrant Exercises 6 month | Proceeds from Warrant Exercises 9 month | Proceeds from Warrant Exercises 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2026-08-13 | -$1.00 derived: sum of 2 quarters · filed 2026-08-13 | $174.37K 10-Q · filed 2026-08-13 | |
| 2026-03-31 | -$1.00 derived: 10-Q/A 6 month − 10-Q 3 month · filed 2026-06-12 | $174.37K 10-Q/A · filed 2026-06-12 | ||
| 2025-12-31 | $174.38K 10-Q · filed 2026-02-17 | |||
| 2025-09-30 | $69.75K 10-K · filed 2025-12-17 | |||
| 2024-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-08-14 | $0.00 derived: sum of 2 quarters · filed 2024-08-14 | $0.00 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-14 | $0.00 10-Q · filed 2024-05-14 | ||
| 2021-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-12-22 | $62.50K derived: sum of 2 quarters · filed 2022-12-22 | $275.00K 10-K · filed 2022-12-22 | |
| 2021-06-30 | $62.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-11 | $275.00K 10-Q · filed 2022-08-11 | ||
| 2021-03-31 | $212.50K 10-Q · filed 2022-05-12 | |||
| 2019-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-12-20 | $0.00 derived: sum of 2 quarters · filed 2019-12-20 | $416.33K 10-K · filed 2019-12-20 | |
| 2019-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-08-14 | $416.33K 10-Q · filed 2019-08-14 | ||
| 2019-03-31 | $416.33K 10-Q · filed 2019-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B |